logo
ScreenersREIT EarningsREIT SectorsMarketplaceLearn
Logo

XOMA Corporation

XOMAO

XOMA Corporation operates as a biotechnology royalty aggregator in Europe, the United States, and the Asia Pacific. The company engages in helping biotech companies for enhancing human health. It acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. The company focuses on early to mid-stagā€¦ read more

Healthcare

Biotechnology

2 years

USD

Exclusive to Premium users

Price

per share adjusted in USD

$25.25

Price

-0.32%

-$0.08

$25.33

Previous Close

$25.30

Open

Premium

52w Discount
Market Cap

$305.202m

Small

Price/Earnings

25.2x

Premium

3y Avg

Premium

5y Avg

Financials Overview

Key metrics over the past few years

-

EBITDA Margin

-

Net Profit Margin

-

Free Cash Flow Margin
Revenue

$38.580m

-

1y CAGR

-

3y CAGR

-

5y CAGR
Earnings

-$11.954m

-

1y CAGR

-

3y CAGR

-

5y CAGR
EPS

$11.71

-

1y CAGR

-

3y CAGR

-

5y CAGR
Book Value

$92.454m

$223.456m

Assets

$131.002m

Liabilities

$114.583m

Debt
Debt to Assets

51.3%

-375.7x

Debt to EBITDA
Free Cash Flow

-$6.686m

-

1y CAGR

-

3y CAGR

-

5y CAGR

Financial Reports

Earnings and other important metrics. Amounts in USD.
No items found.
ā†‘ TopSummaryPriceFinancials
logo
About usFAQ
All the information presented is collected from official and public documents such as: Quarterly and Annual Reports, 10-K (US), Information Form (Canada), Presentations and the Investor Relations (IR) section of the company's website.
The data displayed by alreits.com is solely for informational purposes, we do not recommend the buying, holding or selling of any of the stocks on the website. If you have no experience in the stock market, please talk to your personal licensed investment advisor before making any decisions.